AI and Safety in Laparoscopic Cholecystectomy: A Randomized Controlled Trial
Recruiting
Phase 3
Interventional Study
Laparoscopic Cholecystectomy
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Pivotal Trial
This treatment is in the last trial phase before FDA approval.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 3
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 70 (estimated)
- Sponsor
- University Health Network, Toronto · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Today, the majority of gallbladder removals surgeries are done using minimally invasive techniques through small cuts to help patients recover faster. However, these procedures are technically more challenging because surgeons have a restricted view of the patient's anatomy, which can increase the risk of serious complications. Artificial intelligence (AI) tools have been developed to guide surgeo…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Surgeon participants: Attending surgeons or fellows that perform laparoscopic cholecystectomy at University Health Network.
* Patients participants: Adults 18 years of age and over, scheduled for laparoscopic cholecystectomy surgery.
Exclusion Criteria:
* Surgeon participant…
Contacts